Strides Shasun gets USFDA nod for kidney stone tablets

Strides Shasun said it has received approval from the United States Food and Drug Administration for potassium citrate extended release tablets USP 5 mEq, 10 mEq and 15 mEq.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news